OMedLive

CME Presentations

Pediatric Neuroblastoma


Presentations


Speakers

  • Gregory C. Hedler, MSW, LCSW

    Gregory C. Hedler, MSW, LCSW

    Gregory C. Hedler, MSW, LCSW

    Social Work Supervisor

    Gregory C. Hedler, MSW, LCSW, is a licensed clinical social worker at the Children’s Hospital of Philadelphia (CHOP) in Pennsylvania. Focusing his supportive efforts on newly diagnosed high-risk neuroblastoma, as well as relapsed or refractory neuroblastoma, he offers 13 years of experience in pediatric oncology to these patients and their families, tailoring his therapeutic interventions to meet the nuanced psychosocial needs associated with recurrent and refractory disease. Before joining CHOP, he worked at The Children's Cancer Institute at Hackensack University Medical Center in New Jersey, caring for patients with various types of childhood cancers as well as those with sickle cell disease. Mr Hedler received his master of social work from Fordham University in New York, New York.
  • Jennifer Saggio, MSN, CRNP, CPON

    Jennifer Saggio, MSN, CRNP, CPON

    Jennifer Saggio, MSN, CRNP, CPON

    Neuroblastoma Developmental Therapeutics Advanced Practice Nurse

    Jennifer Saggio, RN, MSN, CRNP, CPON, MSN, is a neuroblastoma nurse practitioner at The Children’s Hospital of Philadelphia (CHOP) in Pennsylvania, and has been a nurse practitioner in the Division of Oncology at CHOP for the past 18 years. Ms Saggio coordinates care for children with recurrent/refractory neuroblastoma, and provides consultations to physicians, nurses, and families in order to meet the complex needs of both hospitalized and ambulatory patients with neuroblastoma. Her team cares for patients who live in the Philadelphia region, those who travel from throughout the United States, and to a large population of international patients as well. She received her graduate degree from the Pediatric Acute/Chronic Care NP Program at the University of Pennsylvania in Philadelphia.
  • Erin A. Armideo, MSN, CRNP, RN, CPON

    Erin A. Armideo, MSN, CRNP, RN, CPON

    Erin A. Armideo, MSN, CRNP, RN, CPON

    Nurse Practitioner

    Erin Armideo, RN, MSN, CRNP, CPON, is a nurse practitioner at The Children’s Hospital of Philadelphia (CHOP) in Pennsylvania, where she began her career as a pediatric oncology nurse. She earned her bachelors of nursing from the Pennsylvania State University and a master’s degree in nursing from the University of Pennsylvania, Pediatric Acute Care Nurse Practitioner program. Ms Armideo has cared for patients with various types of solid tumors in both inpatient and outpatient settings. Her passion is educating patients and families about their child’s disease, treatment and side effects of treatment. She has presented in various forums, including internationally on the management of side effects related to immunotherapy, and has received awards from CHOP and the Philadelphia City Council.

CME Information

Enhancing Supportive Care for Pediatric Patients with High–Risk Neuroblastoma: A Focus on Nursing Practice Strategies


LEARNING OBJECTIVES

  • Review methods to manage various adverse effects associated with neuroblastoma treatments for pediatric patients
  • Formulate effective communication strategies before, during, and after treatment that support pediatric patients with neuroblastoma and their family members

Acknowledgement

This activity is supported by an independent educational grant from United Therapeutics Corporation.

Tuition

Complimentary

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION STATEMENTS

Live Activity

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)&tade;. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

Liver internet activity:

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

Enduring internet activity:

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

Date of Release/Expiration

Live Activity

December 7, 2018 from 11:00am – 12:00pm ET.

Enduring Material

The enduring material will be available from December 7, 2018 to December 7, 2019.

Target Audience

This activity is intended for pediatric oncology nurses, pediatric nurses, oncology nurses, nurse practitioners, nurse managers, infusion nurses, research nurses, and others who care for or have an interest in pediatric patients with high-risk neuroblastoma, such as physicians, physician assistants and social workers.

ESTIMATED TIME TO COMPLETE

This activity consists of one session which should take approximately 1 hour to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To participate in the activity, go to www.OMedLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE OF CONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Jennifer N. Saggio, MSN, CRNP, CPON
Neuroblastoma Developmental Therapeutics Advanced Practice Nurse
Children's Hospital of Philadelphia
None

Erin A. Armideo, MSN, CRNP, RN, CPON
Nurse Practitioner
Children's Hospital of Philadelphia
Consulting Presenter: United Therapeutics

Gregory C. Hedler, MSW, LCSW
Social Work Supervisor
Children's Hospital of Philadelphia
None

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Hamsa Jaganathan, PhD Medical Director
PlatformQ Health Education, LLC
None

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information

Accreditation Support

Please contact the Postgraduate Institute for Medicine at www.pimed.com.

Technical Support

For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com.